window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

amylin analog

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity

    Verdiva Bio has dosed the first patient in a Phase [...]

    July 30, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Fuse Diagnostics raises £1M to scale rapid molecular testing platform
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Medical devices, Research & Development
  • Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
    Categories: Central Nervous System, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • CluePoints brings AI-powered clinical data review to DPHARM 2026
    Categories: Clinical & Regulatory, Digital & Data, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top